Lenacapavir: The 'Breakthrough Of The Year' Drug For HIV Care
A significant breakthrough in treating the Human Immunodeficiency Virus (HIV) came recently with the US Federal Drug ...
News Medical on MSN9h
HIV drug access remains a major challenge despite promising trial results
Promising new drugs to prevent and treat HIV have the potential to transform the response to the disease. But getting these ...
MIT Technology Review7d
Long-acting HIV prevention meds: 10 Breakthrough Technologies 2025
A new drug is hugely effective at protecting people from HIV infection and needs to be injected only twice a year.
‘Pivotal step’: University of Utah biochemist’s HIV research contributes to Science’s ‘Breakthrough of the Year’
Wesley Sundquist’s lab laid foundation for development of a highly effective, long-lasting preventive measure against HIV.
Managed Healthcare Executive3d
WHO to Develop Lenacapavir and HIV Testing Guidelines
A Guideline Development Group (GDG) meeting at the end of the month aims to establish new guidelines for lenacapavir, a twice ...
devdiscourse11d
Revolutionary HIV Drug: Lenacapavir Signals New Hope
Lenacapavir, approved by the US FDA, presents a groundbreaking advancement in the battle against HIV. Developed by Gilead ...
USA Today1mon
Lenacapavir treats and prevents HIV, it does not cure infection | Fact check
The post appears to reference the drug lenacapavir, which reportedly can cost around $40,000 annually in the U.S. and is administered in twice-yearly doses. While the drug appears to be effective ...
Glassman: How Trump can meet his goal of ending AIDS
In Donald Trump’s 2019 State of the Union Address, he made “a commitment to eliminate the HIV epidemic in the United States ...
Gilead Sciences, Inc. (GILD): A Bull Case Theory
We came across a bullish thesis on Gilead Sciences, Inc. (NASDAQ:GILD) on Substack by Magnus Ofstad. In this article, we will ...